Triple-negative breast cancer (TNBC) is a particular clinical subtype characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER2) proteins receptors, making up ~15% of BC [2]. Here, ERBB2 is linked to triple-negative breast carcinoma.